10x Genomics
TXG
$40.49
Share price
-1.84%
Change (1 day)
-4.50%
Change (1 year)
Categories
Operating Margin for 10x Genomics (TXG)
Operating Margin as of October 2023 (TTM): -29.35%
According to 10x Genomics 's latest financial reports and stock price the company's current Operating Margin is -29.35%. At the end of 2022 the company had an Operating Margin of -31.27%.
Operating Margin history for 10x Genomics from 2019 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | -31.27% | 190.24% |
| 2021 | -10.77% | -93.96% |
| 2020 | -178.28% | 1468.25% |
| 2019 | -11.37% | -84.88% |
| 2018 | -75.17% | 198.03% |
| 2017 | -25.22% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -591.52% | 1,915.40% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -129.00% | 339.52% | 🇬🇧 UK |
 Novavax NVAX | -149.57% | 409.61% | 🇺🇸 USA |
 Novocure
NVCR | -37.52% | 27.84% | Jersey |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.